Tech Company Financing Transactions

Minoryx Therapeutics Funding Round

Caixa Capital, Columbus Venture Partners and private investors participated in a $54.7 million Series C funding round for Minoryx Therapeutics. This VC investment round was announced on 5/31/2022.

Transaction Overview

Company Name
Minoryx Therapeutics
Announced On
5/31/2022
Transaction Type
Debt
Venture Equity
Amount
$54,700,000
Round
Series C
Investors

Caixa Capital (Lead Investor)

Columbus Venture Partners (Lead Investor) (Damià Tormo)

Proceeds Purpose
The company will use the money to fund a filing for approval and launch preparations in Europe as well as to support its efforts to bring the drug candidate to market in the U.S.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Av. Ernest Lluch 32 TCM3
Barcelona, 08302
Spain
Phone
+34 93 544 14 66
Website
www.minoryx.com
Email Address
[email protected]
Overview
We are currently focused on Inborn Errors of Metabolism, a group of rare diseases of genetic origin with high unmet medical need. Such diseases are life threatening and highly debilitating, usually with neurological manifestations and affect most severely the pediatric population.
Profile
Minoryx Therapeutics LinkedIn Company Profile
Social Media
Minoryx Therapeutics Company Twitter Account
Company News
Minoryx Therapeutics News
Facebook
Minoryx Therapeutics on Facebook
YouTube
Minoryx Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Marc Martinell
  Marc Martinell LinkedIn Profile  Marc Martinell Twitter Account  Marc Martinell News  Marc Martinell on Facebook
Chief Medical Officer
Uwe Meya
  Uwe Meya LinkedIn Profile  Uwe Meya Twitter Account  Uwe Meya News  Uwe Meya on Facebook
Chief Operating Officer
Didier Le Normand
  Didier Le Normand LinkedIn Profile  Didier Le Normand Twitter Account  Didier Le Normand News  Didier Le Normand on Facebook
VP - Operations
Sílvia Pascual
  Sílvia Pascual LinkedIn Profile  Sílvia Pascual Twitter Account  Sílvia Pascual News  Sílvia Pascual on Facebook
VP - Regulatory Affairs
María Pascual
  María Pascual LinkedIn Profile  María Pascual Twitter Account  María Pascual News  María Pascual on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/31/2022: Hint Health venture capital transaction
Next: 5/31/2022: Culina Health venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.